本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ACRUX LTD

0.015
+0.0017.14%
成交量:52.09万
成交额:7,600.00
市值:611.65万
市盈率:-0.74
高:0.015
开:0.015
低:0.014
收:0.014
52周最高:0.079
52周最低:0.014
股本:4.08亿
流通股本:3.00亿
量比:1.55
换手率:0.17%
股息:- -
股息率:- -
每股收益(TTM):-0.020
每股收益(LYR):-0.020
净资产收益率:-132.33%
总资产收益率:-60.07%
市净率:1.79
市盈率(LYR):-0.75

数据加载中...

公司资料

公司名字:
ACRUX LTD
交易所:
ASX
成立时间:
1998
员工人数:
43
公司地址:
103-113, Stanley Street,West Melbourne,Victoria,Australia
邮编:
3003
传真:
61 3 8379 0101
简介:
Acrux Limited, together with its subsidiaries, develops and commercializes specialty and generic topical pharmaceuticals in Australia, Switzerland, Germany, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.